Cognition Therapeutics, Inc. (NASDAQ:CGTX) Given Average Recommendation of “Buy” by Analysts
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have been given a consensus rating of “Buy” by the seven ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation […]
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have been given a consensus rating of “Buy” by the seven ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation […]
